Member Info for MIKODX

Numptytrader - Maybe I didn't word it properly and I see how it could get misunderstood, they don't have direct company information. What I meant was the MM's know exactly what is going on behind the scenes with the amount of orders coming in and going out. There might be more buys which could indicate something may be going on in the background with the company, or a lot of sells which could indicate targets are not being met. Buys are buys but Sells could be either gains or loss to the stock. They control the shares and know exactly how many shares they have in hand and how many outstanding, so can manipulate the price accordingly.

Trade volume very low but still the price is rising, which cements my point that regardless of trade volume, buy and sells, the MM's control the SP and they know exactly what's going on in the background. Obviously something is going on, maybe things are taking off in Brazil, maybe cash is coming in through some other avenue which is balancing the books or making a profit. Either way the MM's know and are in control.

Twatcher - That's according to CK in one of his presentations, but on Bidstats it says £75.

Don't know what to believe.

https://bidstats.uk/tenders/2020/W43/737280030

There's been a lot of talk in the media today of the vaccine being ready in weeks. The SP has held up well under the circumstances. Investors are still buying shares and the buys are far outweighing the sells. I see more of the same tomorrow, maybe a 60 finish.

A CEO for another stock I'm invested in, today said that he doesn't want to invest any further in antibody testing.
His reason was because he can't see antibody tests which costs between £50 - £100 being used with a £20 vaccine.

What he doesn't realise is the Govt has already done their homework and have managed to get a deal with the
UK-RTC for £20 per antibody test. This is why the UK-RTC will be the main and probably only players that will have
their tests rolled out alongside the vaccine. Bargain price for a gold standard test.

Old but relevant.

https://www.sharebuyers.co.uk/shares/omega-diagnostics-bounces-as-uk-rtc-highlights-rapid-test-as-a-companion-to-covid-19-vaccines/

Open on 52 close on 55, not bad. Decent trading volume with a lot more buys than sells,
proving that investors still believe in this stock. Hopefully we get another decent finish tomorrow.

If Abingdon goes public and manages to raise 20M to expand their manufacturing capabilities ,
surely this weakens Omega's position. I've been here since March and seen ODX drop from
leaders of the consortium to bit part players.

IPO??

We are not a private company so why are you talking out your a$$?

Well maybe you should sell up and go elsewhere if it's not good enough for you.

Make sure to shut the door behind you.

Just received this email from Abingdon Health.

Abingdon Health has completed the FDA Section IV.D notification process, enabling the distribution of the UK-RTC AbC-19™ rapid antibody test for use in the US.

The notification by the US Food and Drug Administration (FDA) permits the AbC-19™ rapid antibody test to be distributed to laboratories certified under CLIA and to healthcare workers across the US for point of care testing.

It can also be found on Abingdon's website.

https://www.abingdonhealth.com/completes-fda-section-iv-d-notification-process/

We opened the week on 19, we are now 25. Why does that look so bad to you?
Try looking at the overall picture instead of watching daily trends.

Another day of high trade volumes.

Looking good.

A tweet always gets this stock moving.

Antibody testing will be a critical component in assessing an
individual's immune response to vaccines, and in determining
whether or when follow-up vaccines/boosters will be needed.

Testing will scale up as new vaccines come on-stream

That's a nice price to start the day. Hopefully we're turning the corner.

Looks like we back on the move North. Good to see.

Lots of potential for ODX but the potential is not being realised, which is why we are where we are.

Tomorrow will make one month since our first order from the UK Govt. Has this first order been completed and when do we expect to see more orders coming in?

On the 9th of October the MOU with the consortium had reached it's expiry date. We've had no update on whether the contract has been renewed or not, and if it has what has changed?

India, China, Africa, lots of potential but where are the Sales?

It's this kind of secrecy and lack of transparency is why we are where we are. We need some good news and fast.

This is great news. We should get an RNS about this very soon.

https://edition.cnn.com/2020/11/10/africa/senegal-coronavirus-rapid-testing-spc-intl/index.html

The 9th November will stay in my mind for a long time. That was the day a Vaccine for Covid 19 was announced, the day most Covid stocks fell to the floor and left investors with stains on their pants.

Since that earth shattering day ODX and the other covid stocks have slowly picked themselves up off the floor. A few will not recover, others will recover but will be handicapped for a long time, some will recover and come back even stronger. With the potential ODX has, they may be one of those that come back stronger.

With a antibody test contract already sealed with the UK govt, and with permission and clearance to sell worldwide, ODX is in a great position. With the antibody tests most likely to be rolled out alongside the vaccine, ODX couldn't be better placed. If you believe in the prospects of this company, load up and hold. If not sell up, move on, and quit moaning.